SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 2/27/17 Bristol Myers Squibb Co 8-K:8,9 2/27/17 4:419K Summit Fin’l Pri… LLC/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 18K 2: EX-1.1 Underwriting Agreement HTML 140K 3: EX-4.1 Instrument Defining the Rights of Security Holders HTML 98K 4: EX-5.1 Opinion re: Legality HTML 10K
Delaware
|
22-0790350
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
Exhibit No.
|
Description
|
|
1.1
|
Underwriting Agreement, dated February 22, 2017, relating to the $750,000,000 1.600% notes due 2019 and $750,000,000 3.250% notes due 2027.
|
|
4.1
|
Ninth Supplemental Indenture, dated as of February 27, 2017, between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as of June 1, 1993.
|
|
4.2
|
Form of $750,000,000 1.600% Notes due 2019 (included as Exhibit A to Exhibit 4.1).
|
|
4.3
|
Form of $750,000,000 3.250% Notes due 2027 (included as Exhibit B to Exhibit 4.1).
|
|
5.1
|
Opinion of Covington & Burling LLP relating to the Notes.
|
|
23.1
|
Consent of Covington & Burling LLP (set forth in Exhibit 5.1).
|
Bristol-Myers Squibb Company
|
||
By:
|
||
Name:
|
||
Title:
|
Vice President, Associate General Counsel and Corporate Secretary
|
Exhibit No.
|
Description
|
|
1.1
|
Underwriting Agreement, dated February 22, 2017, relating to the $750,000,000 1.600% notes due 2019 and $750,000,000 3.250% notes due 2027.
|
|
4.1
|
Ninth Supplemental Indenture, dated as of February 27, 2017, between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as of June 1, 1993.
|
|
4.2
|
Form of $750,000,000 1.600% Notes due 2019 (included as Exhibit A to Exhibit 4.1).
|
|
4.3
|
Form of $750,000,000 3.250% Notes due 2027 (included as Exhibit B to Exhibit 4.1).
|
|
5.1
|
Opinion of Covington & Burling LLP relating to the Notes.
|
|
23.1
|
Consent of Covington & Burling LLP (set forth in Exhibit 5.1).
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period End: | 2/27/17 | |||
2/22/17 | 424B3, FWP | |||
6/1/93 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/13/24 Bristol-Myers Squibb Co. 10-K 12/31/23 148:22M 2/14/23 Bristol-Myers Squibb Co. 10-K 12/31/22 145:23M 2/09/22 Bristol-Myers Squibb Co. 10-K 12/31/21 142:24M 2/10/21 Bristol-Myers Squibb Co. 10-K 12/31/20 143:28M |